[1] |
CAI W, MUELLER C, LI Y J,et al. Post stroke depression and risk of stroke recurrence and mortality:a systematic review and meta-analysis[J]. Ageing Res Rev, 2019, 50:102-109. DOI: 10.1016/j.arr.2019.01.013.
|
[2] |
VILLA R F, FERRARI F, MORETTI A. Post-stroke depression:Mechanisms and pharmacological treatment[J]. Pharmacol Ther, 2018, 184:131-144. DOI: 10.1016/j.pharmthera.2017.11.005.
|
[3] |
|
[4] |
ANDRABI S S, PARVEZ S, TABASSUM H. Ischemic stroke and mitochondria:mechanisms and targets[J]. Protoplasma, 2020, 257(2):335-343. DOI: 10.1007/s00709-019-01439-2.
|
[5] |
DE DIEGO-ADELIÑO J, PORTELLA M J, GÓMEZ-ANSÓN B,et al. Hippocampal abnormalities of glutamate/glutamine,N-acetylaspartate and choline in patients with depression are related to past illness burden[J]. J Psychiatry Neurosci, 2013, 38(2):107-116. DOI: 10.1503/jpn.110185.
|
[6] |
JI X W, WU C L, WANG X C,et al. Monoamine neurotransmitters and fibroblast growth factor-2 in the brains of rats with post-stroke depression[J]. Exp Ther Med, 2014, 8(1):159-164. DOI: 10.3892/etm.2014.1674.
|
[7] |
HAMA S, MURAKAMI T, YAMASHITA H,et al. Neuroanatomic pathways associated with monoaminergic dysregulation after stroke[J]. Int J Geriatr Psychiatry, 2017, 32(6):633-642. DOI: 10.1002/gps.4503.
|
[8] |
ZHOU S J, LIU S, LIU X Q,et al. Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke:a meta-analysis[J]. Medicine (Baltimore), 2020, 99(6):e19062. DOI: 10.1097/MD.0000000000019062.
|
[9] |
MAYEVSKY A, KUTAI-ASIS H, TOLMASOV M. Mitochondrial function and brain Metabolic Score (BMS) in ischemic Stroke:Evaluation of "neuroprotectants" safety and efficacy[J]. Mitochondrion, 2020, 50:170-194. DOI: 10.1016/j.mito.2019.11.005.
|
[10] |
|
[11] |
CAO X, LI L P, WANG Q,et al. Astrocyte-derived ATP modulates depressive-like behaviors[J]. Nat Med, 2013, 19(6):773-777. DOI: 10.1038/nm.3162.
|
[12] |
FERRARI F, VILLA R F. The neurobiology of depression:an integrated overview from biological theories to clinical evidence[J]. Mol Neurobiol, 2017, 54(7):4847-4865. DOI: 10.1007/s12035-016-0032-y.
|
[13] |
|
[14] |
|
[15] |
ALLEN J, ROMAY-TALLON R, BRYMER K J,et al. Mitochondria and mood:mitochondrial dysfunction as a key player in the manifestation of depression[J]. Front Neurosci, 2018, 12:386. DOI: 10.3389/fnins.2018.00386.
|
[16] |
|
[17] |
EMMERZAAL T L, PRESTON G, GEENEN B,et al. Impaired mitochondrial complex I function as a candidate driver in the biological stress response and a concomitant stress-induced brain metabolic reprogramming in male mice[J]. Transl Psychiatry, 2020, 10(1):176. DOI: 10.1038/s41398-020-0858-y.
|
[18] |
AGUIAR A S Jr, STRAGIER E, DA LUZ SCHEFFER D,et al. Effects of exercise on mitochondrial function,neuroplasticity and anxio-depressive behavior of mice[J]. Neuroscience, 2014, 271:56-63. DOI: 10.1016/j.neuroscience.2014.04.027.
|
[19] |
NAGY E E, FRIGY A, SZÁSZ J A,et al. Neuroinflammation and microglia/macrophage phenotype modulate the molecular background of post-stroke depression:a literature review[J]. Exp Ther Med, 2020, 20(3):2510-2523. DOI: 10.3892/etm.2020.8933.
|
[20] |
WIJERATNE T, SALES C. Understanding why post-stroke depression may be the norm rather than the exception:the anatomical and neuroinflammatory correlates of post-stroke depression[J]. J Clin Med, 2021, 10(8):1674. DOI: 10.3390/jcm10081674.
|
[21] |
YANG L L, ZHANG Z J, SUN D M,et al. The serum interleukin-18 is a potential marker for development of post-stroke depression[J]. Neurol Res, 2010, 32(4):340-346. DOI: 10.1179/016164110X12656393665080.
|
[22] |
WU D, ZHANG G C, ZHAO C Y,et al. Interleukin-18 from neurons and microglia mediates depressive behaviors in mice with post-stroke depression[J]. Brain Behav Immun, 2020, 88:411-420. DOI: 10.1016/j.bbi.2020.04.004.
|
[23] |
PIZZINO G, IRRERA N, CUCINOTTA M,et al. Oxidative stress:harms and benefits for human health[J]. Oxid Med Cell Longev, 2017, 2017:8416763. DOI: 10.1155/2017/8416763.
|
[24] |
PETSCHNER P, GONDA X, BAKSA D,et al. Genes linking mitochondrial function,cognitive impairment and depression are associated with endophenotypes serving precision medicine[J]. Neuroscience, 2018, 370:207-217. DOI: 10.1016/j.neuroscience.2017.09.049.
|
[25] |
|
[26] |
CADENAS S. Mitochondrial uncoupling,ROS generation and cardioprotection[J]. Biochim Biophys Acta Bioenerg, 2018, 1859(9):940-950. DOI: 10.1016/j.bbabio.2018.05.019.
|
[27] |
DU R H, WU F F, LU M,et al. Uncoupling protein 2 modulation of the NLRP3 inflammasome in astrocytes and its implications in depression[J]. Redox Biol, 2016, 9:178-187. DOI: 10.1016/j.redox.2016.08.006.
|
[28] |
BAI B C, YANG Y Y, WANG Q,et al. NLRP3 inflammasome in endothelial dysfunction[J]. Cell Death Dis, 2020, 11(9):776. DOI: 10.1038/s41419-020-02985-x.
|
[29] |
YAN C J, DUANMU X Y, ZENG L,et al. Mitochondrial DNA:distribution,mutations,and elimination[J]. Cells, 2019, 8(4):379. DOI: 10.3390/cells8040379.
|
[30] |
WEST A P, SHADEL G S. Mitochondrial DNA in innate immune responses and inflammatory pathology[J]. Nat Rev Immunol, 2017, 17(6):363-375. DOI: 10.1038/nri.2017.21.
|
[31] |
NISSANKA N, MORAES C T. Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease[J]. FEBS Lett, 2018, 592(5):728-742. DOI: 10.1002/1873-3468.12956.
|
[32] |
YANG Y, KARAKHANOVA S, HARTWIG W,et al. Mitochondria and mitochondrial ROS in cancer:novel targets for anticancer therapy[J]. J Cell Physiol, 2016, 231(12):2570-2581. DOI: 10.1002/jcp.25349.
|
[33] |
LIU Q, ZHANG D, HU D,et al. The role of mitochondria in NLRP3 inflammasome activation[J]. Mol Immunol, 2018, 103:115-124. DOI: 10.1016/j.molimm.2018.09.010.
|
[34] |
CZARNY P, WIGNER P, STRYCHARZ J,et al. Mitochondrial DNA copy number,damage,repair and degradation in depressive disorder[J]. World J Biol Psychiatry, 2020, 21(2):91-101. DOI: 10.1080/15622975.2019.1588993.
|
[35] |
KATO T. Neurobiological basis of bipolar disorder:Mitochondrial dysfunction hypothesis and beyond[J]. Schizophr Res, 2017, 187:62-66. DOI: 10.1016/j.schres.2016.10.037.
|
[36] |
ILUT S, STAN A, BLESNEAG A,et al. Factors that influence the severity of post-stroke depression[J]. J Med Life,2017,10(3):167-171.
|
[37] |
TU J, WANG L X, WEN H F,et al. The association of different types of cerebral infarction with post-stroke depression and cognitive impairment[J]. Medicine (Baltimore), 2018, 97(23):e10919. DOI: 10.1097/MD.0000000000010919.
|
[38] |
ZHANG T, JING X, ZHAO X Q,et al. A prospective cohort study of lesion location and its relation to post-stroke depression among Chinese patients[J]. J Affect Disord, 2012, 136(1/2):e83-87. DOI: 10.1016/j.jad.2011.06.014.
|
[39] |
XU X B, LAI Y Y, HUA Z C. Apoptosis and apoptotic body:disease message and therapeutic target potentials[J]. Biosci Rep, 2019, 39(1). DOI: 10.1042/bsr20180992.
|
[40] |
BOCK F J, TAIT S W G. Mitochondria as multifaceted regulators of cell death[J]. Nat Rev Mol Cell Biol, 2020, 21(2):85-100. DOI: 10.1038/s41580-019-0173-8.
|
[41] |
陈东风,房殿春. 线粒体膜通透性转换孔与细胞凋亡[J]. 第三军医大学学报,2004,26(17):1598-1600.
|
[42] |
CHEN Q, GONG B, ALMASAN A. Distinct stages of cytochrome c release from mitochondria:evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis[J]. Cell Death Differ, 2000, 7(2):227-233. DOI: 10.1038/sj.cdd.4400629.
|
[43] |
|
[44] |
史华伟,郭蓉娟,赵振武,等. 醒脾解郁方对抑郁大鼠行为学及海马与骨骼肌线粒体超微结构的影响[J]. 北京中医药大学学报,2017,40(4):284-289.
|
[45] |
YANG J L, MUKDA S, CHEN S D. Diverse roles of mitochondria in ischemic stroke[J]. Redox Biol, 2018, 16:263-275. DOI: 10.1016/j.redox.2018.03.002.
|